Roots Analysis has done a detailed study on At-Home Blood Collection and Micro Sampling Devices market, 2021-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

To order this 190 page report, which features 95+ figures and 110+ tables, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

Key Market Insights

• The ongoing COVID-19 pandemic has accelerated the pace at which the healthcare sector is evolving, thereby, spurring innovations that allow patients to collect blood samples at-home as well as monitor their health remotely
• Presently, close to 50 at-home blood collection and micro sampling devices are available / being developed; majority of the firms engaged in this domain are start ups or small companies located in the US
• Most of the at-home devices intended for collection of whole capillary blood are presently marketed; DBS technology, used for preparation of dried blood spot cards, has emerged as the most popular platform
• In pursuit of gaining a competitive edge, stakeholders are actively expanding their product portfolios and upgrading their devices, via incorporation of advanced features
• Over the years, the intellectual property related to blood collection devices has grown at a commendable pace, with majority of the patents being filed by industry players
• The growing interest of the stakeholders is also reflected from the recent rise in partnership activity; a significant proportion of the deals inked till date were focused on market expansion
• To support the ongoing innovation in this domain, private and public investors have made substantial capital investments, worth ~USD 650 million, in initiatives of various industry stakeholders
• Given the favourable increase in adoption of at-home blood collection and micro sampling devices during the COVID-19 pandemic, the market is anticipated to witness significant growth in the foreseen future

For more information, please visit https://www.rootsanalysis.com/reports/at-home-blood-collection-and-microsampling-devices-market.html

Table of Contents

1. PREFACE
   1.1. Scope of the Report
   1.2.       Research Methodology
   1.3.       Key Questions Answered

1.4.      Chapter Outlines

2.       EXECUTIVE SUMMARY

3. 
   INTRODUCTION
   3.1. Chapter Overview

3.2.      Overview of At-Home Blood Collection and Micro Sampling Devices

3.3.      Applications of Blood Sampling and Testing

3.3.1.    Complete Blood Count

3.3.2.    Basic Metabolic Panel

3.3.3.    Lipoprotein Panel

3.4.      Types of Blood Sampling

3.4.1.    Dried Blood Sampling

3.4.2.    Wet Blood Sampling

3.5.      Benefits of At-Home Blood Collection

3.6.      Methods Used for At-Home Blood Collection

3.6.1.    Fingerstick Method

3.6.2.    Press Button Method

3.6.3.    Heel-stick Method

3.7.      Types of At-Home Blood Collection and Micro Sampling Devices

3.7.1.    Dried Blood Spot Collection Kits

3.7.2.    Microtainer Tubes

3.8.      Future Perspectives

4. MARKET OVERVIEW
   4.         Market Overview

4.1.      Chapter Overview

4.2.       At-Home Blood Collection and Micro Sampling Devices: Overall Market Landscape

4.2.1.    Analysis by Device Class

4.2.2.    Analysis by Current Status of Development

4.2.3.    Analysis by Regulatory Approvals / Certifications Received

4.2.4.    Analysis by Type of Technology

4.2.5.    Analysis by Device Usage

4.2.6     Analysis by Type of Sample

4.2.7.    Analysis by Blood Sample State

4.2.8.    Analysis by Volume of Sample Collected

4.2.9.    Analysis by Puncture Site

4.2.10.  Analysis by Method of Sample Collection

4.2.11.  Analysis by Storage Temperature

4.2.12.  Analysis by Application Area

4.3.      At-Home Blood Collection and Micro Sampling Devices: List of Developers

4.3.1.    Analysis by Year of Establishment

4.3.2.    Analysis by Company Size

4.3.3.    Analysis by Geography

4.3.4.    Analysis by Year of Establishment, Company Size and Location of Headquarters

4.4.      Most Active Players: Analysis by Number of Products

5. PRODUCT COMPETITIVENESS ANALYSIS
   5.1. Chapter Overview

5.2.      Assumptions and Key Input Parameters

5.3.      Methodology

5.3.1.    Product Competitiveness Analysis: North America

5.3.2.    Product Competitiveness Analysis: Europe

5.3.3.    Product Competitiveness Analysis: Asia-Pacific

6. COMPANY PROFILES
   6.1. Chapter Overview

6.2.      EUROIMMUN

6.2.1.    Company Overview

6.2.2.    Product Portfolio

6.2.3.    Recent Developments and Future Outlook

6.3.      Everlywell

6.3.1.    Company Overview

6.3.2.    Product Portfolio

6.3.3.    Recent Developments and Future Outlook

6.4.      Labcorp

6.4.1.    Company Overview

6.4.2.    Product Portfolio

6.4.3.    Recent Developments and Future Outlook

6.5.      Labonovum

6.5.1.    Company Overview

6.5.2.    Product Portfolio

6.5.3.    Recent Developments and Future Outlook

6.6.      Lameditech

6.6.1.    Company Overview

6.6.2.    Product Portfolio

6.6.3.    Recent Developments and Future Outlook

6.7.      Quest Diagnostics

6.7.1.    Company Overview

6.7.2.    Product Portfolio

6.7.3.    Recent Developments and Future Outlook

6.8.      Spot On Sciences

6.8.1.    Company Overview

6.8.2.    Product Portfolio

6.8.3.    Recent Developments and Future Outlook

6.9.      Tasso

6.9.1.    Company Overview

6.9.2.    Product Portfolio

6.9.3.    Recent Developments and Future Outlook

6.10.     Weavr Health

6.10.1.  Company Overview

6.10.2.  Product Portfolio

6.10.3.  Recent Developments and Future Outlook

6.11.     YourBio Health

6.11.1.  Company Overview

6.11.2.  Product Portfolio

6.11.3.  Recent Developments and Future Outlook

7. PATENT ANALYSIS
   7.1. Chapter Overview

7.2.      At-Home Blood Collection and Micro Sampling Devices: Patent Analysis

7.2.1.    Scope and Methodology

7.2.2.    Analysis by Publication Year

7.2.3.    Analysis by Publication Year and Type of Patent

7.2.4.    Analysis by Geography

7.2.5.    Analysis by CPC Symbols

7.2.6.    Analysis by Emerging Focus Area

7.2.7.    Most Active Players: Analysis by Number of Patents

7.2.8.    Patent Benchmarking Analysis

7.2.9.    Patent Valuation Analysis

7.2.10.  Overall Intellectual Property Portfolio: Analysis by Type of Organization

8. PARTNERSHIPS
   8.1. Chapter Overview

8.2.      Partnership Models

8.3.      At-Home Blood Collection and Micro Sampling Devices: List of Partnerships

8.3.1.    Analysis by Year of Partnership

8.3.2.    Analysis by Type of Partnership

8.3.3.    Analysis by Year and Type of Partnership

8.3.4.    Analysis by Focus Area

8.3.5.    Analysis by Year of Partnership and Focus Area

8.3.6.    Analysis by Type of Partnership and Focus Area

8.3.7.    Analysis by Therapeutic Area

8.3.8.    Analysis by Region

8.3.8.1. Continent-wise Distribution

8.3.8.2. Intercontinental and Intracontinental Distribution

8.3.8.3. Country-wise Distribution

8.3.9.    Most Active Players: Analysis by Number of Partnerships

9. FUNDING AND INVESTMENT ANALYSIS
   9.1.      Chapter Overview

9.2.      Types of Funding

9.3.      At-Home Blood Collection and Micro Sampling Devices: Funding and Investment Analysis

9.3.1.    Analysis of Number of Funding Instances by Year

9.3.2.    Analysis by Amount Invested

9.3.3.    Analysis by Type of Funding

9.3.4.    Analysis by Year and Type of Funding

9.3.5.    Analysis of Amount Invested by Geography

9.3.6.    Most Active Players: Analysis by Number of Funding Instances and Amount Invested

9.3.7.    Key Investors: Analysis by Number of Funding Instances

9.3.8.    Analysis by Purpose of Investment

9.3.9.    Analysis by Application Area

10. COST SAVING ANALYSIS
    10.1.     Chapter Overview

10.2.     Key Assumptions and Methodology

10.3.     Overall Cost Saving Potential of At-Home Blood Collection and Micro Sampling Devices

10.3.1.  North America Scenario

10.3.2.  Europe Scenario

10.3.3.  Asia-Pacific Scenario

11. MARKET FORECAST
    11.1. Chapter Overview

11.2.     Forecast Methodology and Assumptions

11.3.     Global At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030

11.3.1.  At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Blood Sample State

11.3.1.1. At-Home Blood Collection and Micro Sampling Devices Market for Dried Blood Samples,      2021- 2030

11.3.1.2. At-Home Blood Collection and Micro Sampling Devices Market for Liquid Blood Samples,     2021-2030

11.3.2.  At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Method of Sample Collection

11.3.2.1. At-Home Blood Collection and Micro Sampling Devices Market for Fingerstick Method of      Sample Collection, 2021-2030

11.3.2.2. At-Home Blood Collection and Micro Sampling Devices Market for Push-Button Method of   Sample Collection, 2021-2030

11.3.3.  At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030:       Analysis by Area of Application

11.3.3.1. At-Home Blood Collection and Micro Sampling Device Market for Diagnostics, 2021-2030

11.3.3.2. At-Home Blood Collection and Micro Sampling Device Market for Research, 2021-2030

11.3.3.3. At-Home Blood Collection and Micro Sampling Device Market for Other Areas of Application,          2021-2030

11.3.4. At-Home Blood Collection and Micro Sampling Devices Market, 2021-2030: Analysis by Region

11.3.4.1. At-Home Blood Collection and Micro Sampling Devices Market in North America, 2021-      2030

11.3.4.2. At-Home Blood Collection and Micro Sampling Devices Market in Europe, 2021-   2030

11.3.4.3. At-Home Blood Collection and Micro Sampling Devices Market in Asia-Pacific, 2021-2030

14. CONCLUSION

15. EXECUTIVE INSIGHT(S)

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Contact Details

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

Ben.johnson@rootsanalysis.com